Home›Companies›Biotech & Pharma›Aperiam Bio

Aperiam Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 27, 2023·Suggest an edit

About Aperiam Bio

Aperiam Bio is a private company based in Austin, Texas, incorporated in 2021 in Delaware. It has reported $7,659,998 raised in two offerings on Form D since March 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 18, 2023Sep 27, 2023$3,999,996target not set2$1.9MEquityRule 506(b)Form D ↗
Jan 31, 2022Mar 7, 2022$3,660,002target not set3$1.2MEquityRule 506(b)Form D ↗
Total, two offerings$7,659,998

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aperiam Bio's Form D filed Sep 27, 2023.

AC
Austin Cole
Executive officer and director

Sources

  1. SECAperiam Bio, Inc. filing history